跳至主要内容
临床试验/CTRI/2024/04/065901
CTRI/2024/04/065901尚未招募3 期

Efficacy of Dashamoola kashaya with Eranda taila in Vata Kaphaja Gridhrasi with special reference to Sciatica- A Randomized controlled clinical trial

Dr Neethu K P1 个研究点目标入组 40 人开始时间: 2024年4月25日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Primary outcomes will be based on Grading Vata-Kaphaja Gridhrasi Symptoms, VAS scale, Tenderness , Roland-Morris Disability Questionnaire,SF-36 QOL

研究概览

简要总结

Low back pain is an extremely common problem with a reported lifetime prevalence ranging from 49 percentage to 70 percentage An estimated 5 percentage to 10 percentage of patients with low back pain have sciaticaThe lifetime incidence of sciatica varies from 13 percentage to 40 percentage The corresponding annual incidence of an episode of sciatica ranges from 1 percentage to 5 percentage Sciatica is a debilitating condition resulting from sciatic nerve or nerve root pathology in which the patient experiences pain and or paresthesia in the sciatic nerve distribution or an associated lumbosacral nerve root A sedentary lifestyle stress improper posture heavy lifting continuous jerky movements long traveling are the potential risk factors In contemporary medicine palliative management NSAIDs and analgesics are the mainstays of pharmacotherapy but their long-term use has various adverse effects  As a last resort surgical procedures are carried out which are quite expensive with their limitations This painful disorder is equated with Gridhrasi in Ayurveda and  Ayurveda offers ample better options in the management of the same Today there is a need to find a drug to manage this condition that is cost effective easily available and has excellent results without hampering the daily routines of the patients In this disease mainly vyana vayu vitiation is observed but kapha is usually associated with dosha So for the treatment of Gridhrasi the drug of choice should have vatashamaka kaphashamaka vatanulomaka dipana pachana and shulaprashamana properties Dashamoola and Eranda are the best choices having such properties to combat this condition Thus Dashamoola Kashaya with eranda taila is taken up for the study to see the effect on symptoms in Vata Kaphaja Gridhrasi

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 Subjects fulfilling the diagnostic criteria irrespective of religion, sex, occupation, and socio-economic status 2 Individuals aged between 20 years to 60 years 3 Unilateral or bilateral radiation of pain in the sciatica nerve distribution.

排除标准

  • 1 History of spinal surgery and vertebral fracture 2 Diagnosed cases of Benign or malignant tumors of the spine 3 Diagnosed cases of Tuberculosis of the Vertebral column 4 Diagnosed Patients with major systematic disorders like uncontrolled Diabetes mellitus and Cardiovascular diseases 5 Patients having back pain due to non-spinal illness will be excluded like Urinary tract infection, Gastrointestinal diseases, and uterine diseases 6 Pregnant and lactating women.

结局指标

主要结局

Primary outcomes will be based on Grading Vata-Kaphaja Gridhrasi Symptoms, VAS scale, Tenderness , Roland-Morris Disability Questionnaire,SF-36 QOL

时间窗: 0th day 15th day 30th day

次要结局

  • Secondary outcomes based on SLR test Walking speed time CRP and ESR(SLR test and Walking speed time (0th day 15th day 30th day) CRP and ESR (0th day and 30th day))

研究者

发起方
Dr Neethu K P
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Neethu K P

KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur Belagavi

研究点 (1)

Loading locations...

相似试验